Korelasi Dosis Akumulasi Obat Kemoterapi Vinkristin Terhadap Kecepatan Hantar Saraf Pada Anak Penderita Leukemia Limfoblastik Akut

37

DAFTAR PUSTAKA

1. Kliegman R, Behrman R, Jenson H. Leukemia. Tubengen D,
penyunting.Dalam : Nelson textbook of pediatric. Edisi ke-18.Philadelphia.
2007
2. Smith M.A, Ries G, Gurney J. Leukemia. SEER Pediatric monograph.
National
cancer
institute.17-21.
Diunduh
dari
Http//www.
seer.cancer.gov/publications/childhood/leukemia. Di akses tanggal 4 Oktober
2013.
3. Atra A, Pinkerton C, Bouffet E, Norton A, Hobson R, Imeson J, Gerrard M.
Acute neurotoxicity in children with advanced stage B-non-hodgkin’s
lymphoma and B- acute Lymphoblastic leukemia treated with the united
kingdom children cancer study group 9002/9003 protocols. Eur J Cancer.
2004; 40: 1346-50

4. Rahman A, Mannan M, Sadeque S. Acute and long- term neurological
complications in children with acute lymphoblastic leukemia. Bangladesh
med res. 2004; 34:90-3
5. Brzezinski K. Chemoterapi-induced peripheral neuropathy. Wapolczesna
Onkol.2012;16(3):258- 63
6. Gilchrist L. Chemotherapy-induced peripheral neuropathy in pediatric cancer
patients. Semin Pediatr Neurol.2012;19:9-17
7. Reinders M, van weerden TW, Fock JM, Gidding CE, Vingerhoets HM, et al.
Mild axonal neuropathy of children during treatment for acute lymphoblastic
leukemia. Eur J Pediatr Neurol.2000;4(5):225-233
8. Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J et al. Vincristineinduced neuropathy as the initial presentation of charcot-marie-tooth disease
in acute lymphoblastic leukemia: a pediatric Oncology Group study. J Pediatr
Hematol Oncol. 2003;25(4):316-320
9. Ariawati K, Windiastuti E, Gatot D. Toksisitas kemoterapi leukemia
limfoblastik akut pada fase induksi dan profilaksis susunan saraf pusat
dengan metotreksat 1 gram. Sari pediatri. 2007;9:252-7
10. Vagace M , Gervasini G. Chemotherapy toxicity in patients with acute
leukemia. Dalam : Mariastefnia A , penyunting. Acute Leukemia- the
scientist’s perspective and challenge. Shanghai: Intech Europe, 2011.h.392413
11. Gomber S, dewan P, Chonker D. Vincristine induced neurotoxicity in cancer

patients. Ind J pediatr. 2010;77(1):97-100

38

12. Park S, Krisnan A, Lin S, Goldstein D, Friendlander M, Kiernan M.
Mechanisms underlying chemotherapy- induced neurotoxicity and the
potential for neuroprotective stragies. Current Medical Chemistry.
2008;15:3083-94
13. Smith O, Hann I. Clinical features and therapy of lymphoblastic leukemia.
Dalam :Arceci R, penyunting. Pediatric hematology.Edisi ke-3. Blackwell.
2006.h. 450-81
14. Permono B, Ugrasena I. Leukemia akut. Dalam : Permono B,Sutaryo,
Ugrasena, Windiastuti, Abdulsalam M, penyunting. Buku ajar hematologi –
onkologi anak cetakan ketiga. Jakarta : Ikatan dokter anak Indonesia,2010.h.
237-47
15. Azhary H, Farooq M, Bhanushali M, Majid A, Kassab M. Periferal
neuropathy: differential diagnosis and management. Am Fam
Physician.2010;81(7):887-92
16. Swaiman F, Ashwal S, Ferriero D. Peripheral neuropathies. Dalam : Susan
P, penyunting.Pediatric neurology principles and practice, edisi ke-4.

Minnesota: Elsivier, 2006.h.1888- 905
17. Schlegel U. Central nervous system toxicity of chemotherapy. European
association of neurooncology magazine. 2008;1(1) :25-9
18. Sul J, DeAngelis L. Neurologic complications of cancer chemotherapy.Semin
Oncol. 2006;33:324-32
19. Edward J, Dropcho. Neurotoxicity of cancer chemotherapy.World Health
Organization.2004;24:420-56
20. Brenner L, Evans W. Rationale for high-dose methotrexate in childhood
acute lymphoblastic leukemia. Ching-Hon Pui,penyunting.Dalam :Treatment
of acute leukemias new directions for clinical research. Totowa:Humana
press.h.339-61
21. Han y, Smith M. Pathobiology of cancer chemotherapy-induced peripheral
neuropathy (CIPN). Frontiers. 2013;4:1-16
22. Andreas A, Argyriou, Bruna J, marmiroli P, Caveletti G. Chemotherapy
induced peripheral neurotoxicity (CIPN): An update. Elsivier. 2011;82:51-77
23. Brigo F, balter R, Marradi P, Ferlisi M, Zaccaron A,et al. Vincristine-related
neuropathy in children with acute lymphoblastic leukemia. J child
Neurol.2012;27(7):867-874
24. Gomber S, dewan P, Chonker D. Vincristine induced neurotoxicity in cancer
patients. Ind J pediatr. 2010;77(1):97-100

25. Ramchandren S, Leonard M, Mody RJ. Peripheral neuropathy in survivors of
childhood acute lymphoblastic leukemia. J peripher Nerv syst. 2009;
14(3):184-189

39

26. Jain P, Gulati S, Seth R, Bakhshi S. Vincristine-induced neuropathy in
childhood ALL (Acute Lymphoblastic Leukemia) Survivors : Prevelance and
Electrophysiological characteristics. J child Neurol. 2013; 1-7
27. Kannarkat G, Lasher E, Schiff D. Neurologic complications of chemotherapy
agents. Cur opin Neurol. 2007;20:719-25
28. Poernomo H. Cara pemeriksaan kecepatan hantar saraf. Widjaja D, Basuki
M, Poernomo H, penyunting. Dalam : Petunjuk praktis elektrodiagnostik.
Bagian ilmu penyakit saraf fakultas kedokteran universitas Airlangga/ RSU
dr. Soetomo. Edisi-1. Surabaya: 2003.h.111-60
29. Clinical medical policy department. Nerve conduct velocity (NCV) and
Eletromyography (EMG) studies. MCS. 2014: 1-10
30. Medical necessity guidelines. Nerve conduction velocity studies including
late response( H-reflex and F wave ). Care allies.2007.1-11
31. Huyn W, Kiernan M. Nerve Conduction studies. AFP. 2011;4:693-697

32. Pease W, Lew H, Johnson E. Johnson’s pratical Elektromyography. Edisi ke4. Toronto: 2015.H 1-21
33. Smith Lavoie,et al. Measuring vincristine-induced peripheral neuropathy in
children with acute lymphoblastic leukemia. Cancer nurs.2013;36(5):E49-60
34. Toopchizadeh V, Barzegar M, Rezamand M, Feiz A. Electrophysiological
consequences of vincristine contained chemotherapy in children : a cohort
study. Journal of pediatric neurologi.2009:351-56
35. Anghelenscu D, Faughnan L, jeha S, Relling M, Hinds P, etall.Neuropathic
pain during treatment for childhood acute lymphoblastic leukemia. Pediatr
Blood Cancer 2011;57(7):1147-53